BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 18455168)

  • 1. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.
    Kuo TK; Hung SP; Chuang CH; Chen CT; Shih YR; Fang SC; Yang VW; Lee OK
    Gastroenterology; 2008 Jun; 134(7):2111-21, 2121.e1-3. PubMed ID: 18455168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kato T; Okochi H; Ochiya T
    J Gastroenterol Hepatol; 2009 Jan; 24(1):70-7. PubMed ID: 18624899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation.
    Zhang S; Chen L; Liu T; Zhang B; Xiang D; Wang Z; Wang Y
    Tissue Eng Part A; 2012 Jul; 18(13-14):1352-64. PubMed ID: 22519429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis.
    Manzini BM; da Silva Santos Duarte A; Sankaramanivel S; Ramos AL; Latuf-Filho P; Escanhoela C; Kharmandayan P; Olalla Saad ST; Boin I; Malheiros Luzo ÂC
    Cytotherapy; 2015 Aug; 17(8):1052-65. PubMed ID: 26139545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model.
    Piryaei A; Valojerdi MR; Shahsavani M; Baharvand H
    Stem Cell Rev Rep; 2011 Mar; 7(1):103-18. PubMed ID: 20182823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure.
    Liu QW; Liu QY; Li JY; Wei L; Ren KK; Zhang XC; Ding T; Xiao L; Zhang WJ; Wu HY; Xin HB
    Stem Cell Res Ther; 2018 Nov; 9(1):321. PubMed ID: 30463600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal mesenchymal stem cells derived from human bone marrow can differentiate into hepatocyte-like cells in injured livers of SCID mice.
    Tao XR; Li WL; Su J; Jin CX; Wang XM; Li JX; Hu JK; Xiang ZH; Lau JT; Hu YP
    J Cell Biochem; 2009 Oct; 108(3):693-704. PubMed ID: 19693776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities.
    Zhang RR; Zheng YW; Li B; Tsuchida T; Ueno Y; Nie YZ; Taniguchi H
    Stem Cell Res Ther; 2015 Mar; 6(1):49. PubMed ID: 25889844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration.
    Oh SH; Witek RP; Bae SH; Zheng D; Jung Y; Piscaglia AC; Petersen BE
    Gastroenterology; 2007 Mar; 132(3):1077-87. PubMed ID: 17383429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of mesenchymal stem cells overexpressing human forkhead box A2 gene in the regeneration of damaged liver tissues.
    Cho JW; Lee CY; Ko Y
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1362-70. PubMed ID: 22432472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver.
    Sharma AD; Cantz T; Richter R; Eckert K; Henschler R; Wilkens L; Jochheim-Richter A; Arseniev L; Ott M
    Am J Pathol; 2005 Aug; 167(2):555-64. PubMed ID: 16049339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regeneration.
    Ma HC; Shi XL; Ren HZ; Yuan XW; Ding YT
    World J Gastroenterol; 2014 Oct; 20(40):14884-94. PubMed ID: 25356048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy-Modulated Human Bone Marrow-Derived Mesenchymal Stem Cells Accelerate Liver Restoration in Mouse Models of Acute Liver Failure.
    Amiri F; Molaei S; Bahadori M; Nasiri F; Deyhim MR; Jalili MA; Nourani MR; Habibi Roudkenar M
    Iran Biomed J; 2016 Jul; 20(3):135-44. PubMed ID: 26899739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.
    Chang HM; Liao YW; Chiang CH; Chen YJ; Lai YH; Chang YL; Chen HL; Jeng SY; Hsieh JH; Peng CH; Li HY; Chien Y; Chen SY; Chen LK; Huo TI
    Int J Mol Sci; 2012; 13(3):3598-3617. PubMed ID: 22489170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplant of Hepatocytes, Undifferentiated Mesenchymal Stem Cells, and In Vitro Hepatocyte-Differentiated Mesenchymal Stem Cells in a Chronic Liver Failure Experimental Model: A Comparative Study.
    El Baz H; Demerdash Z; Kamel M; Atta S; Salah F; Hassan S; Hammam O; Khalil H; Meshaal S; Raafat I
    Exp Clin Transplant; 2018 Feb; 16(1):81-89. PubMed ID: 28585911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human umbilical cord mesenchymal stem cells and derived hepatocyte-like cells exhibit similar therapeutic effects on an acute liver failure mouse model.
    Zhou R; Li Z; He C; Li R; Xia H; Li C; Xiao J; Chen ZY
    PLoS One; 2014; 9(8):e104392. PubMed ID: 25101638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice.
    Woo DH; Kim SK; Lim HJ; Heo J; Park HS; Kang GY; Kim SE; You HJ; Hoeppner DJ; Kim Y; Kwon H; Choi TH; Lee JH; Hong SH; Song KW; Ahn EK; Chenoweth JG; Tesar PJ; McKay RD; Kim JH
    Gastroenterology; 2012 Mar; 142(3):602-11. PubMed ID: 22138358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No contribution of multipotent mesenchymal stromal cells to liver regeneration in a rat model of prolonged hepatic injury.
    Popp FC; Slowik P; Eggenhofer E; Renner P; Lang SA; Stoeltzing O; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
    Stem Cells; 2007 Mar; 25(3):639-45. PubMed ID: 17110617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraportally delivered stem cell spheroids localize in the liver and protect hepatocytes against GalN/LPS-induced fulminant hepatic toxicity.
    Regmi S; Pathak S; Thanh TP; Nguyen TT; Sung JH; Yook S; Kim JO; Yong CS; Choi I; Doh KO; Park PH; Park JB; Seo Y; Kim BK; Lee DM; Moon IJ; Kim HS; Jeong JH
    Stem Cell Res Ther; 2019 Oct; 10(1):230. PubMed ID: 31615539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers.
    Aurich I; Mueller LP; Aurich H; Luetzkendorf J; Tisljar K; Dollinger MM; Schormann W; Walldorf J; Hengstler JG; Fleig WE; Christ B
    Gut; 2007 Mar; 56(3):405-15. PubMed ID: 16928726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.